Research and analysis
Breast screening: Hologic Affirm DBT biopsy system
This report describes a practical evaluation of the Hologic Affirm digital breast tomosynthesis biopsy system in NHS breast screening.
Ref: PHE publications gateway number 2015570 PDF, 3.34MB, 62 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email firstname.lastname@example.org. Please tell us what format you need. It will help us if you say what assistive technology you use.
The overall objective of the evaluation was to evaluate the clinical performance of tomosynthesis biopsy using the Hologic Selenia Dimensions and the Hologic Affirm breast biopsy guidance system, and to evaluate the associated technical issues.
The detailed objectives were to:
- evaluate the usefulness of the Affirm tomosynthesis biopsy system as part of the assessment process
- assess the practical aspects of use and report on the operators’ views and experience
- assess the performance and reliability of the equipment when in use for tomosynthesis biopsies
- report on radiation dose to the breast from imaging during tomosynthesis biopsy